FDA Approved: APTENSIO XR — Original Application (Rhodes Pharmaceuticals L.P.)

View source ↗

Summary

The FDA approved Aptensio XR (methylphenidate hydrochloride) from Rhodes Pharmaceuticals as a new drug product for attention-deficit/hyperactivity disorder. Apt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• APTENSIO XR (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

ORIG AP for APTENSIO XR (METHYLPHENIDATE HYDROCHLORIDE)